title: Targeted therapies and thyroid cancer: an update.
abstract: The treatment of metastatic, progressive thyroid cancer has evolved over recent years. New 'targeted' therapeutic approaches have been developed along with advances in the knowledge of thyroid carcinogenesis and the identification of tumor and endothelial targets. In recent years, results of targeted therapies have shown some benefit in refractory, progressive, differentiated, and medullary thyroid carcinomas but not, until recently, in undifferentiated thyroid carcinoma. We review here the different targeted therapies tested in thyroid cancers.
authors.affiliation: Claude Bernard University, Lyon I, Centre Leon Berard, Lyon, France. delafo@lyon.fnclcc.fr
authors.forename: Christelle
authors.initials: C
authors.lastname: de la Fouchardiere
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Droz
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D018278:Carcinoma, Neuroendocrine; D016503:Drug Delivery Systems; D004727:Endothelium / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D009362:Neoplasm Metastasis; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents